Cite
HARVARD Citation
Strosberg, J. et al. (n.d.). 6LBA 177-Lu-Dotatate significantly improves progression-free survival in patients with midgut neuroendocrine tumours: Results of the phase III NETTER-1 trial. European journal of cancer. pp. S710-. [Online].